Works matching IS 18387640 AND DT 2024 AND VI 14 AND IP 9

Results: 20

Sleep deprivation causes gut dysbiosis impacting on systemic metabolomics leading to premature ovarian insufficiency in adolescent mice.

Published in:

Theranostics, 2024, v. 14, n. 9, p. 3760, doi. 10.7150/thno.95197

By:

Jiamao Yan;
Xiaoyuan Zhang;
Kexin Zhu;
Mubin Yu;
Qingchun Liu;
De Felici, Massimo;
Teng Zhang;
Junjie Wang;
Wei Shen

Publication type:

Article

An injectable magnesium-loaded hydrogel releases hydrogen to promote osteoporotic bone repair via ROS scavenging and immunomodulation.

Published in:

Theranostics, 2024, v. 14, n. 9, p. 3739, doi. 10.7150/thno.97412

By:

Hang Zhou;
Zhongyuan He;
Youde Cao;
Lei Chu;
Bing Liang;
Kexiao Yu;
Zhongliang Deng

Publication type:

Article

FUNDC1 alleviates doxorubicin-induced cardiotoxicity by restoring mitochondrial-endoplasmic reticulum contacts and blocked autophagic flux.

Published in:

Theranostics, 2024, v. 14, n. 9, p. 3719, doi. 10.7150/thno.92771

By:

Weibin He;
Zhongchan Sun;
Guang Tong;
Lin Zeng;
Wenlong He;
Xiaopan Chen;
Cien Zhen;
Pengyuan Chen;
Ning Tan;
Pengcheng He

Publication type:

Article

Enhancing precision: A predictive model for 177Lu-DOTATATE treatment response in neuroendocrine tumors using quantitative 68Ga-DOTATATE PET and clinicopathological biomarkers.

Published in:

Theranostics, 2024, v. 14, n. 9, p. 3708, doi. 10.7150/thno.98053

By:

Akhavanallaf, Azadeh;
Joshi, Sonal;
Mohan, Arathi;
Worden, Francis P.;
Krauss, John C.;
Zaidi, Habib;
Frey, Kirk;
Suresh, Krithika;
Dewaraja, Yuni K.;
Ka Kit Wong

Publication type:

Article

Towards effective CAIX-targeted radionuclide and checkpoint inhibition combination therapy for advanced clear cell renal cell carcinoma.

Published in:

Theranostics, 2024, v. 14, n. 9, p. 3693, doi. 10.7150/thno.96944

By:

Kleinendorst, Simone C.;
Oosterwijk, Egbert;
Molkenboer-Kuenen, Janneke;
Frielink, Cathelijne;
Franssen, Gerben M.;
Boreel, Daan F.;
Tamborino, Giulia;
Gloudemans, Manon;
Hendrikx, Merel;
Kroon, Dennis;
Hillen, Jopp;
Bussink, Johan;
Muselaers, Stijn;
Mulders, Peter;
Konijnenberg, Mark W.;
Wheatcroft, Michael P.;
Twumasi-Boateng, Kwame;
Heskamp, Sandra

Publication type:

Article

Trop2-targeted therapies in solid tumors: advances and future directions.

Published in:

Theranostics, 2024, v. 14, n. 9, p. 3674, doi. 10.7150/thno.98178

By:

Xinlin Liu;
Leina Ma;
Jiyixuan Li;
Li Sun;
Ying Yang;
Ting Liu;
Dongming Xing;
Saisai Yan;
Miao Zhang

Publication type:

Article

Chronic stress dysregulates the Hippo/YAP/14-3-3η pathway and induces mitochondrial damage in basolateral amygdala in a mouse model of depression.

Published in:

Theranostics, 2024, v. 14, n. 9, p. 3653, doi. 10.7150/thno.92676

By:

Yan Zhao;
Yulong Chen;
Chihua Guo;
Pingping Li;
Zhao Cheng;
Lei Zheng;
Baoyong Sha;
Hao Xu;
Xingli Su;
Yunpeng Wang

Publication type:

Article

Modularized supramolecular assemblies for hypoxia-activatable fluorescent visualization and image-guided theranostics.

Published in:

Theranostics, 2024, v. 14, n. 9, p. 3634, doi. 10.7150/thno.95590

By:

Wen Liu;
Bincheng Wang;
Bei Guo;
Junbin Zhu;
Zejun Xu;
Jiayue Xu;
Zhen Wang;
Guodong Sun;
Wei Wang;
Yi Zhang;
Wei Xue

Publication type:

Article

PSMA-PET follow-up to assess response in patients not receiving PSMA therapy: Is there value beyond localization of disease?

Published in:

Theranostics, 2024, v. 14, n. 9, p. 3623, doi. 10.7150/thno.96738

By:

Küper, Alina T.;
Kersting, David;
Telli, Tugce;
Herrmann, Ken;
Rominger, Axel;
Afshar-Oromieh, Ali;
Lopes, Leonor;
Karkampouna, Sofia;
Kuangyu Shi;
Moon Kim;
Hadaschik, Boris;
Darr, Christopher;
Umutlu, Lale;
Fendler, Wolfgang P.;
Seifert, Robert

Publication type:

Article

Highlighting fibroblast plasticity in lung fibrosis: the WI-38 cell line as a model for investigating the myofibroblast and lipofibroblast switch.

Published in:

Theranostics, 2024, v. 14, n. 9, p. 3603, doi. 10.7150/thno.93519

By:

Vásquez-Pacheco, Esmeralda;
Marega, Manuela;
Lingampally, Arun;
Fassy, Julien;
Truchi, Marin;
Goth, Kerstin;
Trygub, Lisa;
Taghizadeh, Sara;
Bartkuhn, Marek;
Alexopoulos, Ioannis;
Dong, Ying;
Lebrigand, Kevin;
Gunther, Andreas;
Chen, Chengshui;
JinSan Zhang;
Cho-Ming Chao;
Al Alam, Denise;
El Agha, Elie;
Mari, Bernard;
Bellusci, Saverio

Publication type:

Article

Extracellular vesicles from apoptotic BMSCs ameliorate osteoporosis via transporting regenerative signals.

Published in:

Theranostics, 2024, v. 14, n. 9, p. 3583, doi. 10.7150/thno.96174

By:

Maojiao Li;
Qi Tang;
Chengcheng Liao;
Zhuo Wang;
Siyuan Zhang;
Qingqing Liang;
Cheng Liang;
Xiaodong Liu;
Jingyi Zhang;
Weidong Tian;
Li Liao

Publication type:

Article

A novel selenium analog of HDACi-based twin drug induces apoptosis and cell cycle arrest via CDC25A to improve prostate cancer therapy.

Published in:

Theranostics, 2024, v. 14, n. 9, p. 3565, doi. 10.7150/thno.92119

By:

Zhiyong Shi;
Miaomiao Liu;
Xiaowen Zhang;
Jingyang Wang;
Junwei Zhang;
Zeyan Peng;
Li Meng;
Ruijing Wang;
Lihong Guo;
Qiang Zhang;
Jing Li;
Liang Yang;
Jie Liu;
Yang Xu;
Jie Yan;
Jianlin Cui;
Shan Ren;
Yang Gao;
Yanming Wang;
Zhi Qi

Publication type:

Article

Metronomic chemotherapy in cancer treatment: new wine in an old bottle.

Published in:

Theranostics, 2024, v. 14, n. 9, p. 3548, doi. 10.7150/thno.95619

By:

Huai-liang Wu;
Han-xing Zhou;
Li-min Chen;
Shu-sen Wang

Publication type:

Article

Single cell analyses reveal the PD-1 blockade response-related immune features in hepatocellular carcinoma.

Published in:

Theranostics, 2024, v. 14, n. 9, p. 3526, doi. 10.7150/thno.95971

By:

Yao Li;
Fengwei Li;
Lei Xu;
Xiaodong Shi;
Hui Xue;
Jianwei Liu;
Shilei Bai;
Yeye Wu;
Zhao Yang;
Feng Xue;
Yong Xia;
Hui Dong;
Feng Shen;
Kui Wang

Publication type:

Article

Targeting endothelial glycolytic reprogramming by tsRNA-1599 for ocular anti-angiogenesis therapy.

Published in:

Theranostics, 2024, v. 14, n. 9, p. 3509, doi. 10.7150/thno.96946

By:

Xiao-yan Han;
Ling-jie Kong;
Duo Li;
Ming Tong;
Xiu-miao Li;
Chen Zhao;
Qin Jiang;
Biao Yan

Publication type:

Article

Deciphering m6A methylation in monocyte-mediated cardiac fibrosis and monocyte-hitchhiked erythrocyte microvesicle biohybrid therapy.

Published in:

Theranostics, 2024, v. 14, n. 9, p. 3486, doi. 10.7150/thno.95664

By:

Jiawen Li;
Li Wei;
Kaifeng Hu;
Yunxiang He;
Guidong Gong;
Qisong Liu;
Yue Zhang;
Kaiyu Zhou;
Junling Guo;
Yimin Hua;
Jun Tang;
Yifei Li

Publication type:

Article

GPAT3 is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma.

Published in:

Theranostics, 2024, v. 14, n. 9, p. 3470, doi. 10.7150/thno.92646

By:

Yu Zhou;
Huakan Zhao;
Ran Ren;
Mingyue Zhou;
Jiangang Zhang;
Zhijuan Wu;
Yu Chen;
Juan Lei;
Yang Chen;
Ying Yu;
Yongsheng Li

Publication type:

Article

Developing targeted therapies for neuroblastoma by dissecting the effects of metabolic reprogramming on tumor microenvironments and progression.

Published in:

Theranostics, 2024, v. 14, n. 9, p. 3439, doi. 10.7150/thno.93962

By:

Wenyi Jin;
Yubiao Zhang;
Zhijie Zhao;
Mingyong Gao

Publication type:

Article

PRL1 and PRL3 promote macropinocytosis via its lipid phosphatase activity.

Published in:

Theranostics, 2024, v. 14, n. 9, p. 3423, doi. 10.7150/thno.93127

By:

Zu Ye;
Chee Ping Ng;
Haidong Liu;
Qimei Bao;
Shengfeng Xu;
Dan Zu;
Yanhua He;
Yixing Huang;
Omer Al-Aidaroos, Abdul Qader;
Ke Guo;
Jie Li;
Lai Ping Yaw;
Qiancheng Xiong;
Min Thura;
Weihui Zheng;
Fenghui Guan;
Xiangdong Cheng;
Yin Shi;
Qi Zeng

Publication type:

Article

Theranostic digital twins: Concept, framework and roadmap towards personalized radiopharmaceutical therapies.

Published in:

Theranostics, 2024, v. 14, n. 9, p. 3404, doi. 10.7150/thno.93973

By:

Abdollahi, Hamid;
Yousefirizi, Fereshteh;
Shiri, Isaac;
Brosch-Lenz, Julia;
Mollaheydar, Elahe;
Fele-Paranj, Ali;
Kuangyu Shi;
Zaidi, Habib;
Alberts, Ian;
Soltani, Madjid;
Uribe, Carlos;
Saboury, Babak;
Rahmim, Arman

Publication type:

Article

Works matching IS 18387640 AND DT 2024 AND VI 14 AND IP 9

Sleep deprivation causes gut dysbiosis impacting on systemic metabolomics leading to premature ovarian insufficiency in adolescent mice.

An injectable magnesium-loaded hydrogel releases hydrogen to promote osteoporotic bone repair via ROS scavenging and immunomodulation.

FUNDC1 alleviates doxorubicin-induced cardiotoxicity by restoring mitochondrial-endoplasmic reticulum contacts and blocked autophagic flux.

Enhancing precision: A predictive model for <sup>177</sup>Lu-DOTATATE treatment response in neuroendocrine tumors using quantitative <sup>68</sup>Ga-DOTATATE PET and clinicopathological biomarkers.

Towards effective CAIX-targeted radionuclide and checkpoint inhibition combination therapy for advanced clear cell renal cell carcinoma.

Trop2-targeted therapies in solid tumors: advances and future directions.

Chronic stress dysregulates the Hippo/YAP/14-3-3η pathway and induces mitochondrial damage in basolateral amygdala in a mouse model of depression.

Modularized supramolecular assemblies for hypoxia-activatable fluorescent visualization and image-guided theranostics.

PSMA-PET follow-up to assess response in patients not receiving PSMA therapy: Is there value beyond localization of disease?

Highlighting fibroblast plasticity in lung fibrosis: the WI-38 cell line as a model for investigating the myofibroblast and lipofibroblast switch.

Extracellular vesicles from apoptotic BMSCs ameliorate osteoporosis via transporting regenerative signals.

A novel selenium analog of HDACi-based twin drug induces apoptosis and cell cycle arrest via CDC25A to improve prostate cancer therapy.

Metronomic chemotherapy in cancer treatment: new wine in an old bottle.

Single cell analyses reveal the PD-1 blockade response-related immune features in hepatocellular carcinoma.

Targeting endothelial glycolytic reprogramming by tsRNA-1599 for ocular anti-angiogenesis therapy.

Deciphering m<sup>6</sup>A methylation in monocyte-mediated cardiac fibrosis and monocyte-hitchhiked erythrocyte microvesicle biohybrid therapy.

GPAT3 is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma.

Developing targeted therapies for neuroblastoma by dissecting the effects of metabolic reprogramming on tumor microenvironments and progression.

PRL1 and PRL3 promote macropinocytosis via its lipid phosphatase activity.

Theranostic digital twins: Concept, framework and roadmap towards personalized radiopharmaceutical therapies.